850 related articles for article (PubMed ID: 23567378)
1. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
Batterham PJ; Bunce D; Cherbuin N; Christensen H
Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
[TBL] [Abstract][Full Text] [Related]
2. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades.
Alexander DM; Williams LM; Gatt JM; Dobson-Stone C; Kuan SA; Todd EG; Schofield PR; Cooper NJ; Gordon E
Biol Psychol; 2007 Jul; 75(3):229-38. PubMed ID: 17433528
[TBL] [Abstract][Full Text] [Related]
3. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of the apolipoprotein E ε4 genotype on cognition during healthy aging.
Knight RG; Tsui HS; Abraham WC; Skeaff CM; McMahon JA; Cutfield NJ
J Clin Exp Neuropsychol; 2014; 36(7):742-50. PubMed ID: 25026037
[TBL] [Abstract][Full Text] [Related]
5. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.
van Vliet P; Oleksik AM; Mooijaart SP; de Craen AJ; Westendorp RG
Neurology; 2009 Mar; 72(9):821-8. PubMed ID: 19255409
[TBL] [Abstract][Full Text] [Related]
6. Association of
Qian J; Betensky RA; Hyman BT; Serrano-Pozo A
Neurology; 2021 May; 96(19):e2414-e2428. PubMed ID: 33771840
[TBL] [Abstract][Full Text] [Related]
7. Substantial effects of apolipoprotein E ε4 on memory decline in very old age: longitudinal findings from a population-based sample.
Praetorius M; Thorvaldsson V; Hassing LB; Johansson B
Neurobiol Aging; 2013 Dec; 34(12):2734-9. PubMed ID: 23855979
[TBL] [Abstract][Full Text] [Related]
8. Salivary cortisol, APOE-ε4 allele and cognitive decline in a prospective study of older persons.
Gerritsen L; Comijs HC; Deeg DJ; Penninx BW; Geerlings MI
Neurobiol Aging; 2011 Sep; 32(9):1615-25. PubMed ID: 19879666
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults.
Swan GE; Lessov-Schlaggar CN; Carmelli D; Schellenberg GD; La Rue A
J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):196-201. PubMed ID: 16306239
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of apolipoprotein E and cognitive function in old age.
Mooijaart SP; van Vliet P; van Heemst D; Rensen PC; Berbée JF; Jolles J; de Craen AJ; Westendorp RG
Ann N Y Acad Sci; 2007 Apr; 1100():148-61. PubMed ID: 17460173
[TBL] [Abstract][Full Text] [Related]
11. APOE ε4 and cognitive function in early life: a meta-analysis.
Ihle A; Bunce D; Kliegel M
Neuropsychology; 2012 May; 26(3):267-77. PubMed ID: 22329498
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E gene in physiological and pathological aging.
Ferri E; Gussago C; Casati M; Mari D; Rossi PD; Ciccone S; Cesari M; Arosio B
Mech Ageing Dev; 2019 Mar; 178():41-45. PubMed ID: 30658061
[TBL] [Abstract][Full Text] [Related]
13. Does possession of apolipoprotein E ɛ4 benefit cognitive function in healthy young adults?
Bunce D; Anstey KJ; Burns R; Christensen H; Easteal S
Neuropsychologia; 2011 Jun; 49(7):1693-7. PubMed ID: 21396385
[TBL] [Abstract][Full Text] [Related]
14. APOE genotype and entorhinal cortex volume in non-demented community-dwelling adults in midlife and early old age.
Bunce D; Anstey KJ; Cherbuin N; Gautam P; Sachdev P; Easteal S
J Alzheimers Dis; 2012; 30(4):935-42. PubMed ID: 22475794
[TBL] [Abstract][Full Text] [Related]
15. The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults.
O'Hara R; Yesavage JA; Kraemer HC; Mauricio M; Friedman LF; Murphy GM
J Am Geriatr Soc; 1998 Dec; 46(12):1493-8. PubMed ID: 9848808
[TBL] [Abstract][Full Text] [Related]
16. APOE genotype and cognitive change in young, middle-aged, and older adults living in the community.
Bunce D; Bielak AA; Anstey KJ; Cherbuin N; Batterham PJ; Easteal S
J Gerontol A Biol Sci Med Sci; 2014 Apr; 69(4):379-86. PubMed ID: 23902936
[TBL] [Abstract][Full Text] [Related]
17. Do apolipoprotein E genotype and educational attainment predict the rate of cognitive decline in normal aging? A 12-year follow-up of the Maastricht Aging Study.
Van Gerven PW; Van Boxtel MP; Ausems EE; Bekers O; Jolles J
Neuropsychology; 2012 Jul; 26(4):459-72. PubMed ID: 22642392
[TBL] [Abstract][Full Text] [Related]
18. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
Insel PS; Hansson O; Mattsson-Carlgren N
JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
[TBL] [Abstract][Full Text] [Related]
20. Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriers.
Alexopoulos P; Richter-Schmidinger T; Horn M; Maus S; Reichel M; Sidiropoulos C; Rhein C; Lewczuk P; Doerfler A; Kornhuber J
J Alzheimers Dis; 2011; 26(2):207-10. PubMed ID: 21606569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]